Trumenba Injection, Suspension
NDC Package 0005-0100-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Trumenba (meningococcal group b vaccine) injection is this vaccine is used to help prevent certain serious, sometimes fatal, bacterial infections (meningitis, meningococcemia). This formulation utilizes a injection, suspension delivery system. Marketed by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, this product is identified by NDC 0005-0100 and is authorized under FDA application BLA125549.

Identification & Billing

NDC Package Code
0005-0100-10
Package Description
10 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0005-0100-01)
Product Code
0005-0100
11-Digit Billing Format
00005010010
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1593135 - meningococcal group B vaccine (MenB generic for Trumenba) 0.5 ML Prefilled Syringe
  • RxCUI: 1593135 - 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe
  • RxCUI: 1593135 - Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 60 MCG / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 60 MCG per 0.5 ML Prefilled Syringe
  • RxCUI: 1593140 - Trumenba vaccine 0.5 ML Prefilled Syringe
  • RxCUI: 1593140 - 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba]

Clinical Specifications

Proprietary Name
Trumenba
Non-Proprietary Name
Meningococcal Group B Vaccine
Substance Name
Neisseria Meningitidis Group B Recombinant Lp2086 A05 Protein Variant Antigen; Neisseria Meningitidis Group B Recombinant Lp2086 B01 Protein Variant Antigen
Dosage Form
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
Usage Information
This vaccine is used to help prevent certain serious, sometimes fatal, bacterial infections (meningitis, meningococcemia). This infection may cause severe problems (hearing loss, brain/nerve problems, paralysis, blindness, seizures, loss of limbs) even with antibiotic treatment. This vaccine works by increasing the body's natural defense (immunity) against the bacteria that cause meningococcal disease. Vaccination is the best way to prevent infection. However, like any vaccine, it may not fully protect everyone who receives it. The brand and dose of vaccine you receive depend on your age. Other vaccines may also be given at the same time, usually in a different site on the body.

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceutical Division Of Wyeth Holdings Llc
Product Type
Vaccine
FDA Application #
BLA125549
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
11-05-2014
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0005-0100). Click a package code to view its specific billing and regulatory data.

0005-0100-05
5 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0005-0100-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0005-0100-10 identifies a specific commercial package of 10 syringe in 1 carton / .5 ml in 1 syringe (0005-0100-01) of Trumenba, a vaccine label labeled by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc. This injection, suspension is formulated for intramuscular use and contains neisseria meningitidis group b recombinant lp2086 a05 protein variant antigen; neisseria meningitidis group b recombinant lp2086 b01 protein variant antigen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc on November 05, 2014. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This vaccine is used to help prevent certain serious, sometimes fatal, bacterial infections (meningitis, meningococcemia). This infection may cause severe problems (hearing loss, brain/nerve problems, paralysis, blindness, seizures, loss of limbs) even with antibiotic treatment. This vaccine works by increasing the body's natural defense (immunity) against the bacteria that cause meningococcal disease. Vaccination is the best way to prevent infection. However, like any vaccine, it may not fully protect everyone who receives it. The brand and dose of vaccine you receive depend on your age. Other vaccines may also be given at the same time, usually in a different site on the body.

How is this Wyeth Pharmaceutical Division Of Wyeth Holdings Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00005010010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0005-0100-10
11-Digit CMS (5-4-2)
00005-0100-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.